Filters
reset allOther countries
Results: 1 to 9 of 9
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
VPS53 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
Pontocerebellar Hypoplasia Panel PreventionGenetics United States | 14 | 12 |
|
Pontocerebellar Hypoplasia via the VPS53 Gene PreventionGenetics United States | 1 | 1 |
|
Prenatal Pontocerebellar Hypoplasia Panel GeneDx United States | 17 | 19 |
|
Results: 1 to 9 of 9
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.